A redeveloped Cae Ras in Wrexham is one of the stadiums Wales has put forward as part of the United Kingdom's bid to host the 2035 Women's World Cup. Fifa announced in April that Wales, England, ...

Patients with type 2 diabetes and inflammatory arthritis who received GLP-1 RAs had lower rates of hypoglycemia, serious infections, and acute kidney injury vs those receiving SGLT2 inhibitors.

GLP-1 RA use was associated with improved cardiometabolic outcomes without significantly affecting mental health outcomes among pediatric patients. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

GLP-1 RAs show greater cardiovascular benefits in type 2 diabetes patients with BMI ≥25 compared to DPP-4 inhibitors. Kidney protection from GLP-1 RAs remains consistent across all BMI categories. The ...

Microsoft open-sourced the MS-BASIC language. Bill Gates would never have seen this coming back in the day. MS-BASIC 1.1 was many developers' first language. In 1976, they rebranded Altair BASIC to ...

The second season of “Wednesday” got split in two, and after a month of waiting to see what would happen to the students of Nevermore, it’s finally time for Part 2. The second season added plenty of ...

When used as first-line therapy in patients with type 2 diabetes (T2D), GLP-1 receptor agonists (RAs) seemed to be more effective than metformin at reducing the risk for dementia, particularly ...

HEC Infra Projects Limited, a prominent firm in the infrastructure sector, has announced its unaudited financial outcomes for the first quarter of the fiscal year 2026. According to the results ...

GLP-1 RAs do not increase risk for acute pancreatitis among individuals with type 2 diabetes. Treatment with GLP-1 receptor agonists (GLP-1 RAs) among patients with type 2 diabetes (T2D) does not ...

There are fewer CV and major limb events among patients with moderate PAD who receive GLP-1 RAs. Patients with moderate peripheral artery disease (PAD) who used glucagon-like peptide-1 receptor ...